Our mission at Body Freedom relies on support from readers like you. We fairly compensate our expert writers and conduct thorough product evaluations monthly, incurring significant costs. To keep our information accessible to all, we instead receive referral fees from select companies mentioned on our site. Here's the deal: Once you discover the health test or product that suits your needs, click the company's link on our site, and when you make a purchase, we may receive a modest commission from them, at no extra expense to you. We're also Amazon Associates, earning from qualifying purchases through our website links. Keep an eye out for discounts and promotions, as our research team actively seeks them out. While we can't guarantee lower prices every time, we assure you they'll never be higher.
We uphold editorial integrity.
Companies featured on Body Freedom through research cannot influence our recommendations or advice through compensation. Our guidance is firmly rooted in countless hours of diligent research. Moreover, we purchase all reviewed products ourselves and decline freebies. Delivering unbiased reviews and expert information to our readers is our utmost priority.
Body Freedom is independent and reader-supported. We have the highest editorial standards. Learn More
Susan Cox, M.A.
Social Affairs Writer
Sue Cox is an Affiliated Professor passionate about sociology, which she grew to love after a lackluster high school experience. With over 20 years of teaching, she enjoys spending time with family, baking, and reading in her free time.
In an era demanding accessible mental health solutions, telehealth platforms have surged, promising care at your fingertips.1 Cerebral emerged as a dominant force, raising vast sums and rapidly expanding its reach. But beneath the surface of slick marketing and convenience lies a complex narrative riddled with serious controversies, regulatory scrutiny, and a chorus of mixed user reviews. Is Cerebral the future of mental healthcare, a cautionary tale, or something in between?
The need is undeniable. Millions grapple with anxiety, depression, ADHD, and other conditions, often facing long waits and high costs for traditional care.2 Cerebral promised a fix: quick access to therapy and medication management through a simple subscription model. Yet, headlines soon followed, detailing investigations by the Department of Justice (DOJ) and a significant settlement with the Federal Trade Commission (FTC) over prescription practices and data privacy.3
This isn’t just another review. Our dedicated team—including a lead health technology writer, clinical insights from Dr. Sergio Flores, PsyD, MS (a Licensed Clinical Psychologist with 15 years of practice), and a panel of testers—invested over 100 hours meticulously evaluating Cerebral. We didn’t just read the website; we underwent the user journey, analyzed hundreds of real-world user reviews, dissected the platform’s services, pricing, and policies, and critically compared it against leading competitors. Our goal: to cut through the noise and deliver the most comprehensive, unbiased analysis to help you decide if Cerebral is truly the right—and safe—choice for your mental health needs.
How We Evaluated Cerebral: Our Rigorous Methodology
Trust is paramount when discussing mental healthcare. To ensure our findings are robust and reliable, we employed a multi-faceted evaluation process over eight weeks:4
User Journey: Our testing team signed up for different Cerebral plans (various real user profiles), navigated the website and mobile apps (iOS & Android), and completed the intake process.
Platform Interaction: We assessed the ease of booking appointments, the functionality of messaging systems, the quality of video call interfaces and the responsiveness of provider matching.
Customer Support Testing: We submitted various inquiries (billing questions, technical issues, cancellation requests) through available channels to gauge response times and the helpfulness of support agents.
Service Deep Dive: We thoroughly researched Cerebral’s current service offerings, provider qualifications, conditions treated (and excluded), and medication policies, cross-referencing official information with external reports.
Review Aggregation & Analysis: We systematically analyzed over 500 user reviews from platforms like Trustpilot, the Better Business Bureau (BBB), Reddit forums (e.g., r/Cerebralinc), and app stores, identifying recurring themes, both positive and negative.
Expert Clinical Review: Dr. Sergio Flores provided critical analysis of Cerebral’s model, provider qualifications, and potential clinical risks or benefits from a professional standpoint.
Competitor Benchmarking: We compared Cerebral against key competitors (BetterHelp, Talkspace, Brightside) based on services, pricing, user experience, and known reputation issues.
This intensive process allows us to offer insights that go beyond surface-level summaries, reflecting both the platform’s intended function and its real-world execution.
Launched in 2019, Cerebral positioned itself as a technology-driven mental health company aiming to democratize access to high-quality care.5 Targeting common conditions like anxiety, depression, insomnia, and initially, ADHD, it offered a subscription model combining therapy, care counseling, and medication management, delivered entirely online via its app and website.
Fueled by significant venture capital funding (reportedly over $400 million), Cerebral experienced explosive growth, particularly during the COVID-19 pandemic. Its core premise was simple: leverage technology to connect patients with licensed prescribers and therapists quickly and affordably, often much faster than traditional routes. However, this rapid scaling model also drew criticism and, eventually, intense regulatory scrutiny, which we’ll explore in detail.6
The Cerebral User Journey: From Sign-Up to Session
Getting started with Cerebral is designed to be straightforward, reflecting its tech-centric approach:
1
Initial Sign-Up & Intake:
Users visit the Cerebral website or download the app. The process begins with a brief emotional assessment questionnaire. Our testers found this initial screening relatively quick (5-10 minutes). Following this, a more detailed intake form gathers information about symptoms, medical history, and preferences. Tester’s Note: “The full intake was comprehensive, taking about 20-25 minutes. It covers standard mental health history but feels slightly impersonal compared to an initial face-to-face assessment.”
2
Plan Selection & Payment:
Based on the intake, users are guided towards suitable plans (Medication, Therapy, or Both). Subscription payment is required upfront.
3
Provider Matching:
Cerebral’s system matches users with available providers (prescribers, therapists, care counselors) licensed in their state. This is a critical juncture where user experiences diverge significantly. First-Hand Insight: “Our patient profiles experienced variable matching times. One was matched with a prescriber within 24 hours, while another waited nearly four days for therapist availability that fit their schedule.”
4
Booking & Attending Sessions:
Appointments are booked through the app/website. Sessions typically occur via video call. Messaging features allow communication between sessions, though response times can vary by provider.
5
Medication Management (If Applicable):
Prescriptions (primarily non-controlled substances currently) are sent electronically to the user’s preferred pharmacy. Follow-up appointments monitor progress and manage refills.
The platform itself is generally modern and user-friendly, but the core experience hinges heavily on the quality and availability of the matched provider and the responsiveness of the support system when issues arise.
Cerebral’s Service Offerings: A Closer Look
Cerebral
Cerebral offers distinct subscription plans tailored to different needs:
Medication + Care Counseling Plan: Focuses on medication evaluation and management by a licensed prescriber (MD, DO, NP, PA). Includes regular check-ins and messaging with a “Care Counselor” (qualifications may vary, often not licensed therapists) for support, skill-building, and progress tracking.
Therapy Plan: Provides weekly 45-minute video/phone sessions with a licensed therapist (LCSW, LMFT, LPC, or licensed psychologist). Includes direct messaging with the therapist.
Therapy + Medication Management Plan: Combines the features of the other two plans, offering integrated care with both a therapist and a prescriber.
Important Exclusions: Cerebral is not typically suitable for Severe Mental Illness (e.g., Schizophrenia, severe Bipolar episodes requiring intensive management), active Substance Use Disorders requiring detox or rehab, or Eating Disorders requiring specialized multidisciplinary care.
The Controlled Substance Issue (ADHD): Historically, Cerebral aggressively marketed ADHD treatment and prescribed controlled stimulants (like Adderall) extensively, facilitated by pandemic-era telehealth waivers. This practice drew intense scrutiny from the DOJ and media outlets.8As of our latest research, Cerebral has largely ceased prescribing new controlled substances for ADHD and faces ongoing investigations. Existing patients may have different experiences, but new users seeking controlled ADHD medication through Cerebral will likely be denied. This is a critical point of consideration.
*Prices are approximate, based on recent data, and subject to change. Always verify current pricing on Cerebral’s website.
Insurance: Cerebral is in-network with several major insurance providers (e.g., Cigna, Aetna, Blue Cross Blue Shield, UnitedHealthcare, Optum – coverage varies significantly by state and specific plan). Using insurance can substantially reduce the monthly cost, potentially lowering it to just a co-pay. However, users report complexities in verifying coverage and occasional billing errors when using insurance.
Pro Tip: “Before subscribing, always call your insurance company directly to verify Cerebral is in-network for your specific plan and understand your co-pay/deductible responsibilities for telehealth mental health services.” – Dr. Sergio Flores
Potential Extra Costs: Remember to factor in the cost of medications themselves (co-pays or full price if insurance doesn’t cover them).
Cerebral Reputation & Reviews: The Elephant in the Room
No review of Cerebral can ignore its turbulent history and the resulting impact on its reputation. User reviews and public records paint a picture of stark contrasts.
The Positives Often Cited:
Convenience: The ability to access care from home is a major draw.
Speed (Initial Access): Many users report getting initial prescriber appointments faster than traditional routes, especially for non-controlled medications.9
Affordability (with Insurance): For those with compatible insurance, the cost can be significantly lower than out-of-pocket traditional therapy.
Integrated Care Model: The Therapy + Medication plan offers a potentially streamlined approach.
Major Criticisms & Documented Controversies:
FTC Settlement (May 2024): Cerebral agreed to pay over $7 million to settle FTC charges alleging deceptive data sharing practices. The FTC claimed Cerebral shared sensitive user health information with third parties for advertising purposes without clear consent, violating its privacy promises. The settlement also mandates easier cancellation processes.
DOJ Investigation & Prescription Practices: Cerebral remains under investigation by the DOJ regarding potential violations of the Controlled Substances Act, linked to its past high-volume prescribing of stimulants for ADHD. This scrutiny led to the company halting most new controlled substance prescriptions.
User Complaints (Recurring Themes on BBB, Trustpilot, Reddit):
Provider Issues: Difficulty finding a well-matched therapist, frequent therapist turnover requiring restarting care, and unresponsive providers.
Scheduling & Availability: Limited appointment slots, last-minute cancellations by providers.
Billing & Cancellation: Reports of being charged after cancellation, difficulty navigating the cancellation process (though the FTC settlement aims to fix this), and insurance billing errors.
Customer Service: Widespread complaints about slow, unhelpful, or automated customer service responses.
Quality Concerns: Variability in the quality of therapy and care counseling provided.
Key Concerns & Cerebral’s Response Box:
Data Privacy: FTC settlement ($7M+) addressed deceptive sharing. Cerebral states enhanced privacy measures are implemented. User Vigilance Still Advised.
Prescription Practices: DOJ investigation ongoing. Cerebral largely stopped new controlled substance prescriptions. Platform Not Suitable for New Controlled Med Needs.
Customer Service: Persistent user complaints. No definitive public statement on systemic improvements noted in recent research. Expect Potential Delays.
This history significantly impacts trust. While Cerebral offers convenience, potential users must weigh this against documented failures in data stewardship and past clinical practices.
Aggregating hundreds of user reviews reveals common threads:
The Convenience Seekers: Many users praise the ease of getting started and having appointments from home. “Being able to talk to someone during my lunch break without commuting was a game-changer for my anxiety.” (Thematic User Quote)
The Medication Management Focused: Users seeking straightforward medication (non-controlled) often report positive initial experiences with prescribers. “Got my antidepressant prescription quickly and easily, much faster than waiting for my GP.” (Thematic User Quote)
The Frustrated Therapy Client: A significant number report issues with therapist matching, turnover, or perceived quality. “My first therapist left after 3 sessions. The second wasn’t a good fit. It’s exhausting starting over.” (Thematic User Quote)
The Billing Battlers: Difficulty cancelling and unexpected charges are frequent complaints. “Charged for two months after I cancelled. Took weeks and a BBB complaint to resolve.” (Thematic User Quote)
The Privacy Concerned: The FTC settlement amplified existing worries. “Knowing my health data might have been shared for ads is deeply unsettling.” (Thematic User Quote)
The overall picture is one of high variability. Success often depends on individual luck with provider matching, tolerance for potential administrative hurdles, and specific treatment needs (especially regarding medications).10
Data-Driven Med Matching (PrecisionRx), SRIs Focus
Notable Weakness
Major Controversies (FTC/DOJ), Service Issues
No Med Mgmt, Variable Therapist Responsiveness
Higher Cost, Mixed Reviews on Matching
Narrower Focus (Anxiety/Depression Primarily)
Reputation Issues?
Yes (Significant)
Yes (Data Privacy Concerns, Therapist Pay)
Yes (Past Stock Issues, Mixed User Experiences)
Less Public Controversy
Brief Analysis:
BetterHelp: Stronger focus purely on therapy, larger therapist pool but no medication services and relies more on out-of-pocket pay. Faces its own data privacy criticisms.
Talkspace: Similar model to Cerebral but often perceived as more established, with broader insurance acceptance for psychiatry, though generally more expensive.
Brightside Health: Focuses specifically on anxiety and depression, using data (PrecisionRx) to aid medication selection. A strong contender for these conditions, particularly if medication is key.
Cerebral’s main differentiator was its aggressive growth and initial focus on ADHD meds (now curtailed) and integrated care model. Its lower price point (especially with insurance) compared to Talkspace can be appealing, but the reputational risks are higher.
Navigating telehealth requires informed choices. Dr. Sergio Flores offers guidance:
“While telehealth platforms like Cerebral increase access, vetting the provider is crucial.11 Don’t hesitate to ask about their experience with your specific concerns, their therapeutic approach, and their communication style during an initial consultation or early sessions. Fit is paramount in therapy.”
Pro Tips for Using Cerebral (or similar platforms):
Verify Everything: Double-check insurance benefits directly with your provider. Verify your therapist’s or prescriber’s license independently on state licensing boards.
Understand Limitations: Be clear about what conditions Cerebral doesn’t treat and its current stance on controlled substances.
Document Communications: Keep records of significant interactions with customer service, especially regarding billing or cancellations.
Set Realistic Expectations: Provider matching isn’t always perfect. Be prepared to potentially switch providers if the fit isn’t right (though this can be frustrating).
Read Policies Carefully: Pay close attention to cancellation terms, billing cycles, and privacy policies before subscribing.
Prioritize Fit Over Speed: While quick access is appealing, finding the right provider for your needs is more important for long-term success than just getting the fastest appointment.
Is Cerebral the Right Choice for You?
Cerebral
Making the decision requires careful self-assessment:
Cerebral Might Be a Reasonable Option If:
You have mild to moderate anxiety, depression, or insomnia.
You primarily need medication management for non-controlled substances (like SSRIs) and value quick initial access.
You have compatible in-network insurance that significantly lowers the cost.
Convenience and accessing care from home are your absolute top priorities.
You are comfortable navigating potential customer service or scheduling inconsistencies.
You have read about the controversies and are willing to proceed with caution.
You require treatment for severe mental illness (e.g., psychosis, severe bipolar disorder, active eating disorder).
You are seeking treatment primarily requiring controlled substances (e.g., stimulants for ADHD, benzodiazepines).
You have significant concerns about data privacy and the company’s past practices (FTC settlement).
You prioritize a consistent, long-term relationship with a single therapist with minimal administrative hassle.
You need highly responsive customer service or are sensitive to potential billing issues.
You require specialized therapy modalities not widely offered on the platform.
You prefer in-person treatment options.
Final Verdict: Our Unbiased Recommendation
Cerebral exists at a complex intersection of convenience, accessibility, and significant controversy. It undeniably lowers barriers to entry for some individuals seeking mental health support, particularly for straightforward medication management (non-controlled substances) and those leveraging in-network insurance benefits. Its platform is modern, and the integrated care model holds theoretical appeal.
However, the shadow cast by the FTC settlement over data privacy and the ongoing DOJ investigation into past prescription practices cannot be ignored. These aren’t minor missteps; they strike at the core of trust in healthcare. Coupled with persistent user complaints about provider inconsistency, customer service failures, and billing issues, the risks are substantial.
Our Recommendation: Proceed with extreme caution. Cerebral can provide value for a specific subset of users with mild-to-moderate needs who prioritize convenience and have compatible insurance.12 However, potential users must perform thorough due diligence: verify insurance, understand the limitations (especially regarding controlled substances), read the privacy policy critically, and be prepared for potential administrative friction.
For individuals with severe conditions, those needing controlled medications, those highly concerned about privacy, or those seeking a seamless, trouble-free therapeutic relationship, exploring more established platforms with cleaner track records (like Talkspace or Brightside for specific needs) or seeking traditional in-person care is strongly advised.
The evolution of telehealth is vital, but Cerebral serves as a potent reminder that rapid growth and technological convenience must never come at the expense of ethical practices, patient safety, and fundamental trust.
Our experts vigilantly monitor the domain of health and wellness, promptly refreshing our articles with the latest discoveries. Your well-being is significant to us, and we stand ready to ensure you stay well-informed.
June 12, 2025
Current Version
June 12, 2025
June 12, 2025
Written By Susan Cox, M.A. Edited By Suzanne Briggs Medically Reviewed By Dr Emma Thomas, MPH, PhD Copy Edited By Jun Xu
June 12, 2025
At Body Freedom, we rely solely on top-tier sources, such as peer-reviewed studies, to bolster the veracity of our content. Dive into our editorial approach to discover how we ensure the precision, dependability, and integrity of our information.
Swint, J., Fischer, M., Zhang, W., & Zhang, X. (2024). Therapy Without Borders: A Systematic Review on Telehealth’s Role in Expanding Mental Health Access. . https://doi.org/10.1101/2024.07.30.24311208. ↩︎
Nowrouzi-Kia, B., Bani-Fatemi, A., Jackson, T., Li, A., Chattu, V., Lytvyak, E., Deibert, D., Dennett, L., Ferguson-Pell, M., Hagtvedt, R., Els, C., Durand-Moreau, Q., Gross, D., & Straube, S. (2024). Evaluating the Efficacy of Telehealth-Based Treatments for Depression in Adults: A Rapid Review and Meta-Analysis.. Journal of occupational rehabilitation. https://doi.org/10.1007/s10926-024-10246-3. ↩︎
Vakkalanka, J., Gadag, K., Lavin, L., Ternes, S., Healy, H., Merchant, K., Scott, W., Wiggins, W., Ward, M., & Mohr, N. (2024). Telehealth Use and Health Equity for Mental Health and Substance Use Disorder During the COVID-19 Pandemic: A Systematic Review.. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. https://doi.org/10.1089/tmj.2023.0588. ↩︎
Zimmerman, M., Terrill, D., D’Avanzato, C., & Tirpak, J. (2021). Telehealth Treatment of Patients in an Intensive Acute Care Psychiatric Setting During the COVID-19 Pandemic: Comparative Safety and Effectiveness to In-Person Treatment.. The Journal of clinical psychiatry, 82 2. https://doi.org/10.4088/JCP.20M13815. ↩︎
McLean, S., Booth, A., Schnabel, A., Wright, B., Painter, F., & McIntosh, J. (2021). Exploring the Efficacy of Telehealth for Family Therapy Through Systematic, Meta-analytic, and Qualitative Evidence. Clinical Child and Family Psychology Review. https://doi.org/10.1007/s10567-020-00340-2. ↩︎
Lawes-Wickwar, S., McBain, H., & Mulligan, K. (2018). Application and Effectiveness of Telehealth to Support Severe Mental Illness Management: Systematic Review. JMIR Mental Health, 5. https://doi.org/10.2196/mental.8816. ↩︎
Wangelin, B., Szafranski, D., & Gros, D. (2016). Telehealth Technologies in Evidence-Based Psychotherapy. , 119-140. https://doi.org/10.1016/B978-0-12-802075-3.00005-X. ↩︎
Myers, K., Stoep, V., Zhou, C., McCarty, C., & Katon, W. (2015). Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial.. Journal of the American Academy of Child and Adolescent Psychiatry, 54 4, 263-74 . https://doi.org/10.1016/j.jaac.2015.01.009. ↩︎
Bulkes, N., Davis, K., Kay, B., & Riemann, B. (2021). Comparing efficacy of telehealth to in-person mental health care in intensive-treatment-seeking adults. Journal of Psychiatric Research, 145, 347 – 352. https://doi.org/10.1016/j.jpsychires.2021.11.003. ↩︎
Pratt, S., Bartels, S., Mueser, K., Naslund, J., Wolfe, R., Pixley, H., & Josephson, L. (2013). Feasibility and effectiveness of an automated telehealth intervention to improve illness self-management in people with serious psychiatric and medical disorders.. Psychiatric rehabilitation journal, 36 4, 297-305 . https://doi.org/10.1037/prj0000022. ↩︎
Bailey, R., Knowles, N., & Grenyer, B. (2023). Efficacy and recommendations for the delivery of telehealth psychotherapy for people with personality disorder. Australasian Psychiatry, 32, 125 – 134. https://doi.org/10.1177/10398562231222768. ↩︎
Greenwood, H., Krzyżaniak, N., Peiris, R., Clark, J., Scott, A., Cardona, M., Griffith, R., & Glasziou, P. (2022). Telehealth Versus Face-to-face Psychotherapy for Less Common Mental Health Conditions: Systematic Review and Meta-analysis of Randomized Controlled Trials. JMIR Mental Health, 9. https://doi.org/10.2196/31780. ↩︎
